ObjectivesTo evaluate the prevalence and patterns of antiretroviral (ARV) drug resistance (ARV-DR) among ARV drug-naïve, recently infected persons with HIV in the 4-year interval (2003)(2004)(2005)(2006) after the inception of the National Access to ARV Programme for People who have AIDS in Thailand.
MethodsCross-sectional study of patients with recent HIV infection for HIV risks, ARV-DR risks and baseline ARV-DR.
ResultsSeven of the 305 patients (2%) had baseline ARV-DR. Via contract tracing, all seven patients with transmitted ARV-DR identified sexual partners with prior ARV treatment failure and had documented low (o75%) ARV adherence. Annual ARV-DR increased from 0 to 5.2% (P 5 0.06) between 2003 and 2006.
ConclusionsReport of sexual partners with potential HIV and ARV drug exposures can prompt baseline ARV-DR testing of at-risk individuals, while behavioural interventions for adherence and safer sex are refined to minimize the emergence of resistance to generic, fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.